Hydroxychloroquine 치료 후 발생한 과다색소침착Hydroxychloroquine-induced Cutaneous Hyperpigmentation
- Other Titles
- Hydroxychloroquine-induced Cutaneous Hyperpigmentation
- Authors
- 노현수; 최원준; 고주연; 노영석
- Issue Date
- 2011
- Publisher
- 대한피부과학회
- Keywords
- Antimalarial; Hydroxychroloquine; Hyperpigmentation
- Citation
- Korean Journal of Dermatology, v.49, no.08, pp.743 - 747
- Indexed
- SCOPUS
KCI
- Journal Title
- Korean Journal of Dermatology
- Volume
- 49
- Number
- 08
- Start Page
- 743
- End Page
- 747
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/169372
- ISSN
- 0494-4739
- Abstract
- The antimalarials have been commonly described for the treatment of several connective tissue diseases. Among adverse effects of antimalarials, skin hyperpigmentation has been easily overlooked for its slow onset, but it may be a marker at risk of ocular side effects. Moreover, most cases of hyperpigmentation have been reported from chloroquine, but rarely hydroxychloroquine (HCQ). We experienced two patients who showed skin pigmentation during administration of HCQ. The first case was a 53-year-old woman presented with dark brown macules on the neck and ashy-colored patches on the buttock. The second was a 75-year-old woman presented with bluish-gray patches on both shins. Before hyperpigmentation developed, each patient had been treated with HCQ 400 mg per day for two years and five months, respectively. Two years ago after skin hyperpigmentation the first patients was found to have retinal pigmentation under the fundoscopy, so that HCQ was discontinued.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 피부과학교실 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.